The Cytosolic DNA-Sensing CGAS-STING Pathway in Cancer

Overview

Journal Cancer Discov

Specialty Oncology

Date 2019 Dec 20

PMID 31852718

Citations 456

Authors

John Kwon

Samuel F Bakhoum

Affiliations

Soon will be listed here.

Abstract

The recognition of DNA as an immune-stimulatory molecule is an evolutionarily conserved mechanism to initiate rapid innate immune responses against microbial pathogens. The cGAS-STING pathway was discovered as an important DNA-sensing machinery in innate immunity and viral defense. Recent advances have now expanded the roles of cGAS-STING to cancer. Highly aggressive, unstable tumors have evolved to co-opt this program to drive tumorigenic behaviors. In this review, we discuss the link between the cGAS-STING DNA-sensing pathway and antitumor immunity as well as cancer progression, genomic instability, the tumor microenvironment, and pharmacologic strategies for cancer therapy. SIGNIFICANCE: The cGAS-STING pathway is an evolutionarily conserved defense mechanism against viral infections. Given its role in activating immune surveillance, it has been assumed that this pathway primarily functions as a tumor suppressor. Yet, mounting evidence now suggests that depending on the context, cGAS-STING signaling can also have tumor and metastasis-promoting functions, and its chronic activation can paradoxically induce an immune-suppressive tumor microenvironment.

Citing Articles

Induction of translation-suppressive G3BP1 stress granules and interferon-signaling cGAS condensates by transfected plasmid DNA.

Majerciak V, Zheng Z Hlife. 2025; 3(1):21-37.

PMID: 40078969 PMC: 11902918. DOI: 10.1016/j.hlife.2024.11.005.

PCK1 inhibits cGAS-STING activation by consumption of GTP to promote tumor immune evasion.

Qin W, Duan Y, Hu Z, Hou Y, Wen T, Ouyang Y J Exp Med. 2025; 222(5).

PMID: 40048154 PMC: 11893166. DOI: 10.1084/jem.20240902.

Neutrophil Extracellular Traps Promote Pancreatic Cancer Progression via the STING Pathway.

Qu M, Zhu C, Sun C, Zhu S, Zhang H, Miao C Gastroenterol Res Pract. 2025; 2025:4950214.

PMID: 40046958 PMC: 11882324. DOI: 10.1155/grp/4950214.

ADSL-generated fumarate binds and inhibits STING to promote tumour immune evasion.

Duan Y, Hu Z, Han P, Lei B, Wang S, Wang Z Nat Cell Biol. 2025; .

PMID: 40033100 DOI: 10.1038/s41556-025-01627-8.

LCAT in Cancer Biology: Embracing Epigenetic Regulation, Immune Interactions, and Therapeutic Implications.

Gao M, Zhang W, Li X, Li S, Wang W, Han P Int J Mol Sci. 2025; 26(4).

PMID: 40003919 PMC: 11855027. DOI: 10.3390/ijms26041453.

References

Senovilla L, Vitale I, Martins I, Tailler M, Pailleret C, Michaud M . An immunosurveillance mechanism controls cancer cell ploidy. Science. 2012; 337(6102):1678-84. DOI: 10.1126/science.1224922. View

Parkes E, Walker S, Taggart L, McCabe N, Knight L, Wilkinson R . Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer. J Natl Cancer Inst. 2016; 109(1). PMC: 5441301. DOI: 10.1093/jnci/djw199. View

Sharma P, Hu-Lieskovan S, Wargo J, Ribas A . Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy. Cell. 2017; 168(4):707-723. PMC: 5391692. DOI: 10.1016/j.cell.2017.01.017. View

Li J, Bakhoum S . Expanding the Role of STING in Cellular Homeostasis and Transformation. Trends Cancer. 2019; 5(4):195-197. PMC: 8290631. DOI: 10.1016/j.trecan.2019.02.001. View

Fu J, Kanne D, Leong M, Glickman L, McWhirter S, Lemmens E . STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade. Sci Transl Med. 2015; 7(283):283ra52. PMC: 4504692. DOI: 10.1126/scitranslmed.aaa4306. View

Corrales L, Glickman L, McWhirter S, Kanne D, Sivick K, Katibah G . Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity. Cell Rep. 2015; 11(7):1018-30. PMC: 4440852. DOI: 10.1016/j.celrep.2015.04.031. View

Georgilis A, Klotz S, Hanley C, Herranz N, Weirich B, Morancho B . PTBP1-Mediated Alternative Splicing Regulates the Inflammatory Secretome and the Pro-tumorigenic Effects of Senescent Cells. Cancer Cell. 2018; 34(1):85-102.e9. PMC: 6048363. DOI: 10.1016/j.ccell.2018.06.007. View

Martin M, Hiroyasu A, Marena Guzman R, Roberts S, Goodman A . Analysis of Drosophila STING Reveals an Evolutionarily Conserved Antimicrobial Function. Cell Rep. 2018; 23(12):3537-3550.e6. PMC: 6114933. DOI: 10.1016/j.celrep.2018.05.029. View

Ferris R, Blumenschein Jr G, Fayette J, Guigay J, Colevas A, Licitra L . Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. N Engl J Med. 2016; 375(19):1856-1867. PMC: 5564292. DOI: 10.1056/NEJMoa1602252. View

10.

Riley J, Quarato G, Cloix C, Lopez J, OPrey J, Pearson M . Mitochondrial inner membrane permeabilisation enables mtDNA release during apoptosis. EMBO J. 2018; 37(17). PMC: 6120664. DOI: 10.15252/embj.201899238. View

11.

Motzer R, Escudier B, Mcdermott D, George S, Hammers H, Srinivas S . Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma. N Engl J Med. 2015; 373(19):1803-13. PMC: 5719487. DOI: 10.1056/NEJMoa1510665. View

12.

Sun W, Yang J . Functional mechanisms for human tumor suppressors. J Cancer. 2010; 1:136-40. PMC: 2948218. DOI: 10.7150/jca.1.136. View

13.

Phillip West A, Khoury-Hanold W, Staron M, Tal M, Pineda C, Lang S . Mitochondrial DNA stress primes the antiviral innate immune response. Nature. 2015; 520(7548):553-7. PMC: 4409480. DOI: 10.1038/nature14156. View

14.

Zhou W, Whiteley A, de Oliveira Mann C, Morehouse B, Nowak R, Fischer E . Structure of the Human cGAS-DNA Complex Reveals Enhanced Control of Immune Surveillance. Cell. 2018; 174(2):300-311.e11. PMC: 6084792. DOI: 10.1016/j.cell.2018.06.026. View

15.

Gentili M, Lahaye X, Nadalin F, P F Nader G, Lombardi E, Herve S . The N-Terminal Domain of cGAS Determines Preferential Association with Centromeric DNA and Innate Immune Activation in the Nucleus. Cell Rep. 2019; 26(13):3798. PMC: 6444014. DOI: 10.1016/j.celrep.2019.03.049. View

16.

Henson P . Dampening inflammation. Nat Immunol. 2005; 6(12):1179-81. DOI: 10.1038/ni1205-1179. View

17.

Canadas I, Thummalapalli R, Kim J, Kitajima S, Jenkins R, Christensen C . Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses. Nat Med. 2018; 24(8):1143-1150. PMC: 6082722. DOI: 10.1038/s41591-018-0116-5. View

18.

Marcus A, Mao A, Lensink-Vasan M, Wang L, Vance R, Raulet D . Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response. Immunity. 2018; 49(4):754-763.e4. PMC: 6488306. DOI: 10.1016/j.immuni.2018.09.016. View

19.

Chiocca E . Oncolytic viruses. Nat Rev Cancer. 2002; 2(12):938-50. DOI: 10.1038/nrc948. View

20.

Luo D, Ding S, Vela A, Kohlway A, Lindenbach B, Pyle A . Structural insights into RNA recognition by RIG-I. Cell. 2011; 147(2):409-22. PMC: 3222294. DOI: 10.1016/j.cell.2011.09.023. View